January 2022: CTIS Training Update

European Medicines Agency (EMA) updated the page Clinical Trials Information System (CTIS): online modular training program on January 28, 2022, by adding new documents in Modules 23 – Transitional Trials:

  1.  FAQs: Transition of trials from EudraCT to CTIS – Module 23: It includes  answers for questions related to creating, submitting, and evaluating transitional trials and the roles and permissions involved in the process
  2.  Member states’ guide: Transition of trials from EudraCT to CTIS – Module 23: It provides an overview on transition trials, its process of evaluation and it also provides steps to update the status of transitional trails in EudraCT for the Member States with screenshots for better understanding
  3.  Sponsors’ guide: Transition of trials from EudraCT to CTIS – Module 23: It provides an overview on transitional trials, steps to create and submit transitional trials and their notifications, steps to submit summary results, and in brief the roles and permissions involved in the process

For more information, please click here.